The Jackson Laboratory collaborates to help the NIH fight rare diseases
Independent nonprofit biomedical research institute The Jackson Laboratory (JAX) has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a new $17M contract with the National Institute of Health’s National Center for the Advancement of Translational Sciences, for the purposes of creating new animal models and performing pharmacology studies to better understand and study diseases or treatments, especially for rare and neglected diseases. The combined capabilities of the team members represent some of the best talents in the world to help the NIH in creating or characterizing novel disease models to address unmet needs. Diseases such as sickle cell disease or other ailments have been difficult to fight without proper animal model resources, indicates Dr. Jake McDonald, Principal Investigator of the overall contract. Read more
Share This Story, Choose Your Platform!